We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

MRTN:NASDAQMarten Transport, Ltd. Analysis

Data as of 2026-04-18 - not real-time

$14.87

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Marten Transport is trading in a bullish technical environment, with the 20‑day moving average sitting above both the 50‑day and 200‑day averages and a MACD histogram that remains positive, indicating upward momentum. However, the RSI has climbed into overbought territory, suggesting that the recent price gains may be nearing exhaustion. Fundamentally, the stock appears significantly overvalued – its price‑to‑earnings multiple is more than double the industry average and the discounted cash‑flow model estimates a fair value well below the current market price. Despite a modest dividend yield, the payout ratio exceeds 100% and free cash flow is negative, raising questions about dividend sustainability.
The balance sheet is strong with minimal debt, but operating margins are thin and revenue growth is negative, limiting upside potential. Analyst consensus remains a buy with a target price modestly above the current level, implying only limited upside. Given the high short‑term volatility and the overbought technical signal, caution is warranted while the longer‑term outlook is tempered by valuation and cash‑flow concerns.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bullish MACD with positive histogram
  • RSI in overbought range
  • Price approaching short‑term resistance

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Analyst consensus of buy with modest upside
  • Strong balance sheet and low debt
  • Current price still below analyst target

Long Term

> 3 years
Neutral
Model confidence: 5/10

Key Factors

  • Significant overvaluation relative to peers
  • Negative free cash flow and high payout ratio
  • Thin operating margins and declining revenue

Key Metrics & Analysis

Financial Health

Revenue Growth-8.80%
Profit Margin1.97%
P/E Ratio70.8
ROE2.27%
ROA0.71%
Debt/Equity0.06
P/B Ratio1.6
Op. Cash Flow$93.5M
Free Cash Flow$-32551250
Industry P/E31.3

Technical Analysis

TrendBullish
RSI70.5
Support$11.91
Resistance$14.88
MA 20$13.51
MA 50$13.20
MA 200$11.97
MACDBullish
VolumeStable
Fear & Greed Index90.21

Valuation

Fair Value$11.34
Target Price$16.00
Upside/Downside7.60%
GradeOvervalued
TypeGrowth
Dividend Yield1.61%

Risk Assessment

Beta1.08
Volatility40.95%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.